Morphological parameters able to predict BRAFV600E‐mutated malignancies on thyroid fine‐needle aspiration cytology: Our institutional experience. Issue 12 (25th August 2014)

• Record Type: Journal Article
• Authors: Rossi, Esther Diana; Bizzarro, Tommaso; Martini, Maurizio; Capodimonti, Sara; Fadda, Guido; Larocca, Luigi Maria; Schmitt, Fernando
• Is Part Of: Cancer cytopathology. Volume 122:Issue 12(2014:Dec.)
• Page Start: 883
• Page End: 891
• Publication Date: 2014-08-25
• Subjects: Cancer -- Cytopathology -- Periodicals; Pathology, Cellular -- Periodicals; Cytology -- Technique -- Periodicals; 611.01815
• DOI: 10.1002/cncy.21475
• Languages: English
• ISSNs: 1934-662X

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cncy21475-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>The <italic>BRAF<sup>V600E</sup></italic> mutation is the most common diagnostic/prognostic marker in papillary thyroid carcinoma (PTC). Its evaluation is typically performed with DNA‐based techniques; nonetheless, a few articles have recently proposed the morphological prediction of <italic>BRAF<sup>V600E</sup></italic> in histological PTCs. We investigated this morphological parameter in our cytological series.</p> </sec> <sec id="cncy21475-sec-0002" sec-type="section"> <title>METHODS</title> <p>We re‐analyzed all 72 cytohistological samples diagnosed as positive for malignancy (favoring PTC) on fine‐needle aspiration cytology from January 2012 to December 2013. We included 22 male patients and 50 female patients. The cytological cases were processed with liquid‐based cytology. We performed molecular analysis and immunocytochemistry for the VE1 <italic>BRAF<sup>V600E</sup></italic> antibody.</p> </sec> <sec id="cncy21475-sec-0003" sec-type="section"> <title>RESULTS</title> <p>We reported 47 mutated cases and 25 wild‐type (WT) cases with 100% cytohistological concordance. The cytological evaluations revealed plump cells (abundant eosinophilic cytoplasm and PTC nuclei) in all 47 mutated cases, with only 6 having a focal plump cell component (≤20% cells). Furthermore, 5 of the 25 WT cases showed focal plump cells. A distinctive sickle nuclear shape was found only in the mutated cases. VE1 yielded 100% positivity for all 24 mutated cases that were tested, including 3 cases with focal plump cells.</p> </sec> <sec id="cncy21475-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>We demonstrated that the <italic>BRAF<sup>V600E</sup></italic> mutation might be predicted in cytological samples on the basis of some specific morphological features. Although the detection of plump cells (mainly focal) was also observed in WT cases, the detection of sickle‐shaped nuclei provided the highest specificity and sensitivity as a predictive mutational parameter. These morphological features might be a valid tool for selecting cases for molecular analysis. <bold><italic>Cancer (Cancer Cytopathol)</italic> 2014;122:883–891</bold>. © <italic>2014 American Cancer Society</italic>.</p> </sec> </abstract>